Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone to reduce myocardial fibrosis in atrial fibrillation
2013-000797-30Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of spironolactone in Atrial fibrillation (AFib) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Myocardial extracellular volume. Started Oct 2013; status: completed.
02
Drugs
spironolactone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2013-000797-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000797-30.